The Business Journals26d
Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval. Cingulate Inc. obtained a $5 million loan that ...
The FDA Continues to Intimidate Doctors and Defraud the American Public
Affordable Plasma Interventions Can Have Significant Health and Economic Benefits to Prevent or Manage Age-Related Conditions ...
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine ...
Say goodbye to Red Dye No.3, parents rejoice after FDA ban
KANSAS CITY, Mo. (KCTV) - A big change is coming to some of your favorite snacks and drinks sold in the U.S. On Wednesday, ...
WDAF-TV4d
FDA floats plan to make cigarettes nonaddictive, but its fate rests with Trump
President-elect Donald Trump and his health nominees have not commented on the measure, but a similar effort led by Trump’s first FDA commissioner, Dr. Scott Gottlieb, was sidelined during his ...
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics
VisiRose Inc. (”VisiRose” or the “Company”), a privately-held, clinical-stage biotechnology company developing novel ocular ...
Becker's Hospital Review1d
3 states get green light to sue FDA over mifepristone access
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
WDAF-TV3d
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
The pouches have been available for more than a decade as FDA reviewed company data intended to show the products can serve as an alternative to cigarettes and other traditional tobacco products.